| Company Name: | Amarin Corp PLC | | | Ticker Symbol: | AMRN | | CIK Number: | 0000897448 | | WWW Address: | http://www.amarincorp.com |
| CEO: | Mr. John F. Thero | | No. of Employees: | 215 |
| Common Issue Type: | CS | | Business Description: | Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Other [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 17.26 |  0.43 | 17.25 | 17.26 | 16.95 | 18.02 | 17.05 | 2407256 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,707.6 | 330.7 | 0.00 | -0.39 | 0.00 | 0.0 | 0.0 | 23.34 - 2.35 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 17.79 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 5,707.6 | mil |
| Latest Shares Outstanding | 330.7 | mil |
| Earnings pS (EPS) | -0.39 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 432,479 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 1.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.20 | % |
| Gross Profit Margin | 76.2 | % |
| EBITDA Margin | -46.6 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 83.8 | % |
| Return on Assets (ROA) | -42.6 | % |
| Return on Equity (ROE) | -567.8 | % |
| Return on Capital Invested (ROCI) | -89.0 | % |
| Current Ratio | 2.4 | |
| Leverage Ratio (Assets/Equity) | 3.0 | |
| Interest Cover | -12.1 | |
| Total Debt/Equity (Gearing Ratio) | 0.62 | |
| LT Debt/Total Capital | 23.0 | % |
| Working Capital pS | 0.67 | $ |
| Cash pS | 0.72 | $ |
| Book-Value pS | 0.36 | $ |
| Tangible Book-Value pS | 0.37 | $ |
| Cash Flow pS | -0.40 | $ |
| Free Cash Flow pS | -0.40 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 49.50 | |
| Price/Tangible Book Ratio | 0.00 | |
| Price/Cash Flow | | |
| Price/Free Cash Flow | | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 9.3 | | 4,305,102 | |
| 4 Weeks | 19.75 | 16.20 | 18.06 | -1.5 | | 4,910,873 | 98,217,462 |
| 13 Weeks | 23.25 | 16.20 | 17.54 | 1.4 | | 7,439,068 | 468,661,320 |
| 26 Weeks | 23.25 | 11.75 | 17.33 | 2.7 | | 7,578,593 | 932,167,015 |
| 52 Weeks | 23.34 | 2.35 | 3.10 | 473.9 | | 8,809,154 | 2,202,288,702 |
| YTD | 23.25 | 11.75 | - | 37.0 | | 7,665,426 | 728,215,477 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 17.03 | 17.29 | 18.71 | 18.13 | 15.27 | 0.00 | 0.00 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.54 | 0.6 | 0.41 |
| Income | | 0.0 | |
| Dividend | | 0.0 | |
| Capital Spending | | NA | |
| R&D | 34.92 | NA | 42.07 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 0.0 | 0.0 | 0.0 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.24 | 0.24 | -0.71 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 57.23 |
| Current Ratio | 2.4 |
| Quick Ratio (Acid Test) | 2.0 |
| Liquidity Ratio (Cash) | 3.18 |
| Receivables Turnover | 4.1 |
| Average Collection Period | 88 |
| Working Capital/Equity | 144.9 |
| Working Capital pS | 0.67 |
| Cash-Flow pS | -0.32 |
| Free Cash-Flow pS | -0.32 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.06 |
| Financial Leverage Ratio (Assets/Equity) | 0.6 |
| Debt Ratio | 20.8 |
| Total Debt/Equity (Gearing Ratio) | 0.62 |
| LT Debt/Equity | 0.35 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 57.4 |
| Interest Cover | -12.1 |
| Interest/Capital Invested | 5.82 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 15.25 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -50.60 |
| Enterprise Value (EV)/Free Cash Flow | -59.46 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.00 |
| Price/Book Ratio - LTM | 49.50 |
| Price/Cash Flow Ratio | |
| Price/Free Cash Flow Ratio - LTM | |
| Price/Sales Ratio | 0.00 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 7.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.00 |
| Tangible Book Value pS - LTM | 0.37 |
| Book Value pS - LTM | 0.36 |
| Capital Invested pS | 0.64 |
| Cash pS - LTM | 0.72 |
| Cash Flow pS - LTM | -0.40 |
| Free Cash Flow pS - LTM | -0.40 |
| Earnings pS (EPS) | -0.39 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -41.34 |
| Free Cash Flow Margin 5YEAR AVG | -70.36 |
| Net Profit Margin | -0.5 |
| Net Profit Margin - 5YEAR AVRG. | -0.9 |
| Equity Productivity | 1.76 |
| Return on Equity (ROE) | -5.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | |
| Capital Invested Productivity | 1.09 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | |
| Assets Productivity | 0.80 |
| Return on Assets (ROA) | -0.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | -0.5 |
| Gross Profit Margin | 76.2 |
| Gross Profit Margin - 5YEAR AVRG. | 0.7 |
| EBITDA Margin - LTM | -46.6 |
| EBIT Margin - LTM | -46.9 |
| Pre-Tax Profit Margin | -0.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -0.8 |
| Effective Tax Rate | -0.7 |
| Effective Tax Rate - 5YEAR AVRG. | -1.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | |
| Revenue per Employee | 432,479 |
| Net Income per Employee | |
| Average Collection Period | |
| Receivables Turnover | 4.1 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 1.2 |
| Inventory/Sales | 25.2 |
| Accounts Payble/Sales | 16.42 |
| Assets/Revenue | 1.25 |
| Net Working Capital Turnover | 1.04 |
| Fixed Assets Turnover | 29.70 |
| Total Assets Turnover | 0.8 |
| Revenue per $ Cash | 0.96 |
| Revenue per $ Plant | 3638.32 |
| Revenue per $ Common Equity | 1.50 |
| Revenue per $ Capital Invested | 1.09 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 99.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 1.0 |
| Research & Devlopment (R&D) as % of Revenue | 24.4 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 24.4 |
|
|  
| | |  |  | | |
